Home>Healthcare
- July 27, 2022
Oral pill for COVID-19 approved by regulator
China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus.
- May 06, 2022
Ningbo upgrades COVID-19 checkup capacity
More than 7,000 nucleic acid testing sites had been built in Ningbo, East China's Zhejiang province as of May 4, according to the Ningbo Municipal Healthcare Commission.
- April 21, 2022
FAQs about antigen self-testing for COVD-19
China has approved COVID-19 antigen testing as a supplementary means to improve early detection, and 10 domestically made antigen kits have been allowed for home use.
- January 29, 2022
Outbreak probe: Virus initially spread from object to person
Catering equipment company could be source of latest epidemic in Hangzhou
- January 18, 2022
Concerted efforts give child cancer patients new hope
Prompt diagnosis and treatment key to saving young lives
- December 24, 2021
New antibody drug to boost COVID fight
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.
- December 14, 2021
Mainland reports first case of COVID-19 Omicron variant
The Chinese mainland reported on Monday its first case of the highly transmissible Omicron COVID-19 variant in Tianjin as authorities in Zhejiang province stepped up measures to control outbreaks of the Delta strain
- December 01, 2021
What we know about the Omicron variant so far
Answers to commonly-asked questions about the Omicron variant of COVID-19.